At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 18 enrolled
Drug / intervention
Venlafaxine 25 mg Tablets +1 moredrug
Likely dose
Venlafaxine 25 mg Tabletsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, 2-Way Crossover, Bioequivalence Study of Venlafaxine 25 mg Tablets and Effexor® 25 mg Tablets Administered as 1 x 25 mg Tablet in Healthy Subjects Under Fed Conditions
In Brief
A Phase 1 clinical trial evaluating Venlafaxine 25 mg Tablets and Effexor® 25 mg Tablets for Healthy. Completed, enrolled 18 participants across 2 sites.
Detailed Summary
The objective of this study is to compare the rate and extent of absorption of venlafaxine 25 mg tablets (test) versus Effexor® (reference) administered as 1 x 25 mg tablet under fed conditions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesCanada
Collaborators--
Timeline
Phase 1CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2002
Primary CompletionDec 2002
First PostedFeb 2009
TodayJul 2026
First PostedFeb 3, 2009
Enrollment StartDec 1, 2002
Primary CompletionDec 1, 2002
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 17.4 years ago
Interventions
Venlafaxine 25 mg Tabletsdrug
1 x 25 mg, single-dose fasting
Effexor® 25 mg Tabletsdrug
1 x 25 mg, single-dose fasting